explore -WSS

explore

author：comprehensive 2025-09-06 03:32:22 - browse：3256

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear.

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. Morgan Healthcare Conference, and describing why it thinks AI, running on Nvidia computers, could dramatically increase the number of new medicines that are created while reducing their cost, ushering in an age of “digital biology.”

When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Mass General, Mayo Clinic look to monetize custom

focus

WSS

AI for drug discovery: Experts on separating hype from reality

TikTok, Instagram influencers need more rules for drug ads

BIO to announce reorganization, senior leaders expected to depart

Can gargling with Listerine treat gonorrhea of the mouth?

HHS's proposed rule does nothing to address the climate crisis

TikTok, Instagram influencers need more rules for drug ads

explore

explore

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Can gargling with Listerine treat gonorrhea of the mouth?

Novavax promises a turnaround & Lilly roils the obesity market

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Brain technologies pose threats that are all too real, experts warn

Affirmative action in medical school literally saved lives

As health system earnings go up, health insurance stocks go down

Jerome Adams on the need for new antivirals for Covid

Novel spinal cord stimulator treats paralysis without surgery

focus

Novel spinal cord stimulator treats paralysis without surgery

Crowdfunding for medical bills sidesteps core problem, author says

Mass General, Mayo Clinic look to monetize custom

Medicare drug price lawsuits could be good politics for Biden

Novel spinal cord stimulator treats paralysis without surgery

Lawmakers grill UnitedHealth CEO on Change cyberattack

entertainment

knowledge

focus

focus